PSX
47
2
CL
58
2
LB
63
22
STI
14
-17
FLR
58
3
TSCO
49
5
DOW
44
10
BMY
60
2
PFG
45
3
WDC
47
4
ACN
52
3
DTE
56
2
UPS
60
9
CPB
30
6
SIG
52
3
A
43
2
PYPL
54
2
WAT
55
2
WU
32
2
VRSN
53
-4
PSX
47
2
CL
58
2
LB
63
22
STI
14
-17
FLR
58
3
TSCO
49
5
DOW
44
10
BMY
60
2
PFG
45
3
WDC
47
4
ACN
52
3
DTE
56
2
UPS
60
9
CPB
30
6
SIG
52
3
A
43
2
PYPL
54
2
WAT
55
2
WU
32
2
VRSN
53
-4
Financhill
Back

Takeda Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison

Sell
20

TAK
Takeda Pharmaceutical

Last Price:
13.37
Seasonality Move:
5.04%
Sell
49

SOLTF
Nxera Pharma

Last Price:
8.05
Seasonality Move:
18.65%
Sell
20
Takeda Pharmaceutical (TAK) is a Sell

Is Takeda Pharmaceutical a Buy, Sell or Hold?

  • The current Takeda Pharmaceutical [TAK] share price is $13.38. The Score for TAK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • TAK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Nxera Pharma (SOLTF) is a Sell

Is Nxera Pharma a Buy, Sell or Hold?

  • The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TAK Stock Price Chart

What is Takeda Pharmaceutical's stock price today?

  • The Takeda Pharmaceutical share price today is $13.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TAK is experiencing slight buying pressure.

SOLTF Stock Price Chart

What is Nxera Pharma's stock price today?

  • The Nxera Pharma share price today is $8.05
    The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.

TAK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 36.35 Sell
Chaikin Money Flow: 519370 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.49 - 13.99) Sell
Bollinger Bands (100): (13.55 - 14.67) Sell

SOLTF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 52.73 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.37 - 8.05) Buy
Bollinger Bands (100): (7.99 - 10.09) Sell

TAK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.49 Sell
20-day SMA: 13.7 Sell
50-day SMA: 14.11 Sell
200-day SMA: 13.89 Sell
8-day EMA: 13.48 Sell
20-day EMA: 13.67 Sell
50-day EMA: 13.94 Sell
200-day EMA: 14.07 Sell

SOLTF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.05 Sell
20-day SMA: 7.75 Buy
50-day SMA: 8.28 Sell
200-day SMA: 9.4 Sell
8-day EMA: 8.02 Buy
20-day EMA: 7.95 Buy
50-day EMA: 8.25 Sell
200-day EMA: 9.38 Sell

Takeda Pharmaceutical Earnings Growth & TAK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nxera Pharma Earnings Growth & SOLTF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Takeda Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nxera Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):